Atypical antipsychotics

-Pine and -done groups.

-Pine group.

  • Clozapine
  • Olanzapine
  • Quetiapine

-Done and -azole group.

  • Risperidone (Risperdal)
  • Ziprazidone (Geodon)
  • Lurasidone (Latuda)
  • Aripiprazole

 

The difference between dystonia, dyskinesia, akinesia, bradykinesia, Akathisia.

The motor side effects of antipsychotics can be divided into 5 categories.

  1. Dystonias
  2. Parkinsonism
  3. Akathisia
  4. Withdrawal dyskinesias
  5. Tardive dyskinesias

 

MOA
Clozapine Antagonizes
-dopamine D2 receptors,
-serotonin 5-HT2 receptors,
-alpha adrenergic receptors,
-cholinergic muscarinic receptors, -others
Olanzapine  Antagonizes
-dopamine D2 receptors,
-serotonin 5-HT2 receptors,
-other receptors (thienobenzodiazepine)
Quetiapine Antagonizes
-dopamine D2 receptors,
-serotonin 5-HT2 receptors,
-other receptors
Risperidone  Antagonizes
-dopamine D2 receptors,
-serotonin 5-HT2 receptors,
-other receptors
Ziprasidone  Antagonizes
-dopamine D2 receptors,
-serotonin 5-HT2 receptors,
-other receptors
Lurasidone  Antagonizes
-dopamine D2 receptors,
-serotonin 5-HT2 receptors,
-other receptors
Aripiprazole Partially agonizes
-dopamine D2 receptors,
-serotonin 5-HT1A receptors,
Antagonizes
-Serotonin 5-HT2A receptors.
  • Dopamine is a vasopressor. We use it to raise blood pressure in patients with shock. Something that blocks dopamine will hypotension, which is one of the side effects of antipsychotics.
  • Dopamine as a vasopressor has different effects that vary based on the dosing rate. It has effects on the heart and SVR as the dose increases.
  • In Parkinson’s disease, brain cells, especially in the substantia nigra, don’t produce enough dopamine. There is a lack of dopamine. When you use medications like the antipsychotics that block dopamine, you get Parkinsonism (or the symptoms of Parkinson’s disease) as side effects.

 

 

Comparative Risk of Adverse Effects of Antipsychotic Medications*

ADVERSE EFFECT Second Generation Antipsychotics
CLOZAPINE OLANZAPINE QUETIAPINE RISPERIDONE ZIPRASIDONE ARIPIPRAZOLE 

Anticholinergic effects

+++

+

+

0

0

 0

Dyslipidemia

+++

+++

++

+

0

 0

Extrapyramidal symptoms

0

+

0

++

+

 +

Hyperprolactinemia

0

+

0

+++

+

0

Neuroleptic malignant syndrome

+

+

+

+

+

 +

Postural hypotension

+++

+

++

++

+

+

Prolonged QT interval

+

+

+

+

++

+

Sedation

+++

++

++

+

+

 +

Seizures

+++

+

+

+

+

 +

Sexual dysfunction

+

+

+

++

+

 +

Type 2 diabetes mellitus

++

++

+

+

+

 +

Weight gain

+++

+++

++

++

0

 0

note0 = rare; + = lower risk; ++ = medium risk; +++ = higher risk.

 

Source: CMAJ June 21, 2005 172 (13) 1703-1711

 

CMAJ June 21, 2005 172 (13) 1703-1711

 

References
CMAJ. 2005 Jun 21;172(13):1703-11. https://www.ncbi.nlm.nih.gov/pubmed/15967975
Am Fam Physician. 2010 Mar 1;81(5):617-622. http://www.aafp.org/afp/2010/0301/p617.html
print